Imaging of tumour neovasculature by targeting the TGF-β binding receptor endoglin

European Journal of Cancer

Volumn 36, Issue 5, 2000, Pages 675-681

  Bredow, S ^a   Lewin, M ^a   Hofmann, B ^a   Marecos, E ^a   Weissleder, R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Angiogenesis; Endoglin; Imaging; TGF receptor; Tumour neovasculature

Indexed keywords

BIOCHEMICAL MARKER; ENDOGLIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANGIOGENESIS; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM; HUMAN; HUMAN CELL; IMAGING; IMMUNOHISTOLOGY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR VASCULARIZATION;

ANTIGENS, CD; HUMANS; IMMUNOHISTOCHEMISTRY; MELANOMA, EXPERIMENTAL; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, CELL SURFACE; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0034060755     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00335-4     Document Type: Article

References (30)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1:1995;27-31.
2. Shima D.T., Saunders K.B., Gougos A., D'Amore P.A. Alterations in gene expression associated with changes in the state of endothelial differentiation. Differentiation. 58:1995;217-226.
3. Burrows F.J., Watanabe Y., Thorpe P.E. A murine model for antibody-directed targeting of vascular endothelial cells in solid tumors. Cancer Res. 52:1992;5954-5962.
4. Denekamp J. Vasculature as a target for tumor therapy. Prog. Appl. Microcirc. 4:1984;28-38.
5. Thorpe P.E., Derbyshire E.J. Targeting the vasculature of solid tumors. J. Controlled Release. 48:1997;277-288.
6. Burrows F., Derbyshire E., Tazzari P.et al. Up-regulation of endoglin on vascular endothelial cells in human solid tumors. implications for diagnosis and therapy Clin. Cancer Res. 1:1995;1623-1634.
7. Matsuno F., Haruta Y., Kondo M., Tsai H., Barcos M., Seon B.K. Induction of lasting complete regression of preformed distinct solid tumors by targeting the tumor vasculature using two new anti-endoglin monoclonal antibodies. Clin. Cancer Res. 5:1999;371-382.
8. Passe T.J., Bluemke D.A., Siegelman S.S. Tumor angiogenesis. tutorial on implications for imaging Radiology. 203:1997;593-600.
9. Lewin M., Bredow S., Sergeyev N., Marecos E., Bogdanov A. Jr., Weissleder R. In vivo assessment of VEGF induced angiogenesis. Int. J. Cancer. 83:1999;798-802.
10. Weissleder R., Cheng H., Marecos E., Kwong K., Bogdanov A. Mapping of tumour vascular and interstitial volume fractions non-invasively in vivo. Eur. J. Cancer. 34:1998;1448-1454.
11. Neri D., Carnemolla B., Nissim A.et al. Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform. Nat. Biotechnol. 15:1997;1271-1275.
12. 3-targeted magnetic resonance imaging. Nature Med. 4:1998;623-626.
13. Kumar P., Wang J.M., Bernabeu C. CD 105 and angiogenesis. J. Pathol. 178:1996;363-366.
14. Krupinski J., Kaluza J., Kumar P., Kumar S., Wang J.M. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke. 25:1994;1794-1798.
15. Westphal J.R., Willems H.W., Schalkwijk C.J.M., Ruiter D.J., de Waal M.W. A new 180 kDa dermal endothelial cell activation antigen. in vitro and in situ characteristics J. Invest. Dermatol. 100:1993;27-34.
16. Wang J.M., Kumar S., Pye D., Haboubi N., Al-Nakib L. Breast carcinoma. comparative study of tumor vasculature using two endothelial markers J. Natl. Cancer Inst. 86:1994;386-388.
17. St Jaques S., Cymerman U., Pece N., Letarte M. Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells. Endocrinology. 314:1994;2645-2657.
18. Cheifetz S., Bellón T., Calés C.et al. Endoglin is a component of the transforming growth factor β receptor system in human endothelial cells. J. Biol. Chem. 267:1992;19027-19030.
19. Bredow S., Guha-Thakurta N., Taishi P., Obál F. Jr., Krueger J.M. Diurnal variations of tumor necrosis factor alpha mRNA and alpha-tubulin mRNA in rat brain. Neuroimmunomodulation. 4:1997;84-90.
20. Marecos E., Weissleder R., Bogdanov A. Jr. Antibody-mediated versus nontargeted delivery in a human small cell lung carcinoma model. Bioconjugate Chem. 9:1998;184-191.
21. Ge A.Z., Butcher E.C. Cloning and expression of a cDNA encoding mouse endoglin, an endothelial cell TGF-beta ligand. Gene. 138:1994;201-206.
22. Lastres P., Letamendía A., Zhang H.et al. Endoglin modulates cellular responses to TGF-β1. J. Cell. Biol. 133:1996;1109-1121.
23. Adam P.J., Clesham G.J., Weissberg P.L. Expression of endoglin mRNA and protein in human vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 247:1998;33-37.
24. Letamendía A., Lastres P., Almendro N.et al. Endoglin, a component of the TGF-beta receptor system, is a differentiation marker of human choriocarcinoma cells. Int. J. Cancer. 76:1998;541-546.
25. Altomonte M., Montagner R., Fonsatti E.et al. Expression and structural features of endoglin (CD 105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma. Br. J. Cancer. 74:1996;1586-1591.
26. Bodey B., Bodey B. Jr., Siegel S.E.et al. Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma. Anticancer Res. 18:1998;2701-2710.
27. Harris A. Anti-angiogenesis therapy and strategies for integrating it with adjuvant therapy. Recent Results Cancer Res. 152:1998;341-352.
28. McAllister K.A., Grogg K.M., Johnson D.W.et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nature Genet. 8:1994;345-351.
29. Li D.Y., Sorensen L.K., Brooke B.S.et al. Defective angiogenesis in mice lacking endoglin. Science. 284:1999;1534-1537.
30. Kumar S., Ghellal A., Li C.et al. Breast carcinoma. vascular density determined using CD 105 antibody correlates with tumor prognosis Cancer Res. 59:1999;856-861.